Қатерлі ісікке қарсы күрескер және дәл медицинаның пионері Кэти Джусти

Kathy Giusti is a business leader and a healthcare disrupter. She is a two time cancer survivor having been diagnosed with multiple myeloma and breast cancer. Kathy Co Founded the Multiple Myeloma Research Foundation (the MMRF) where she was CEO and president for nearly two decades. She also co chaired the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, which she helped found, as a Senior Fellow at Harvard Business School. Kathy is recognized as a pioneer in precision medicine,

Kathy has been named one of Time magazine's 100 Most Influential People in the world. and ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders.

Kathy held executive positions with increasing responsibility in consumer marketing with Gillette/Procter & Gamble and in the pharmaceutical sector of the healthcare industry with Merck & Co. and G. D. Searle & Company (now Pfizer).

In 1998, with her identical twin sister Karen Andrews, Kathy Founded the Multiple Myeloma Research Foundation (the MMRF). The MMRF’s mission is to accelerate a cure for each and every multiple myeloma patient. As founder, president, CEO, and Chief Mission Officer Kathy has led the MMRF in establishing partnerships and collaborative research models in precision medicine including the Multiple Myeloma Research Consortium (MMRC), the MMRF CoMMpass™ study, CureCloud, the Right Track, and the Myeloma Investment Fund. Under Giusti the MMRF has raised more than $500 million to fund research, 15 drugs have been approved to treat multiple myeloma, and many clinical trials are underway. These efforts have accelerated the pace at which treatments are brought to patients and more than tripled patients' survival. Giusti has co led the formation of the Kraft Accelerator Leadership Forum, a group of CEOs from disease focused foundations working together to address the most important challenges, share best practices, and accelerate precision medicine models.

In 1996, Kathy Giusti was diagnosed with multiple myeloma, an incurable blood cancer. When diagnosed, Giusti was 37 years old and was given three years to live. At the time of her diagnosis, there were no new treatments in the pipeline for multiple myeloma. In 2022, Kathy was diagnosed with early stage breast cancer as well.